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Our recent study showed that SAG/RBX2 E3 ubiquitin ligase regulates apoptosis and vasculogenesis by promoting
degradation of NOXA and NF1, and co-operates with Kras to promote lung tumorigenesis by activating NFκB and
mTOR pathways via targeted degradation of tumor suppressive substrates including IκB, DEPTOR, p21 and p27.
Here we investigated the role of Sag/Rbx2 E3 ligase in cellular senescence and immortalization of mouse
embryonic fibroblasts (MEFs) and report that Sag is required for proper cell proliferation and KrasG12D-induced
immortalization. Sag inactivation by genetic deletion remarkably suppresses cell proliferation by inducing
senescence, which is associated with accumulation of p16, but not p53. Mechanistically, Sag deletion caused
accumulation of Jun-B, a substrate of Sag-Fbxw7 E3 ligase and a transcription factor that drives p16 transcription.
Importantly, senescence triggered by Sag deletion can be largely rescued by simultaneous deletion of Cdkn2a, the
p16 encoding gene, indicating its causal role. Furthermore, KrasG12D-induced immortalization can also be
abrogated by Sag deletion via senescence induction, which is again rescued by simultaneous deletion of Cdkn2a.
Finally, we found that Sag deletion inactivates KrasG12D activity and block the MAPK signaling pathway, together
with accumulated p16, to induce senescence. Taken together, our results demonstrated that Sag is a KrasG12D-
cooperating oncogene required for KrasG12D-induced immortalization and transformation, and targeting SAG-SCF
E3 ligase may, therefore, have therapeutic value for senescence-based cancer treatment.
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CRL (Cullin-RING ligase) is the multi-complex E3 ubiquitin ligase
with SCF (Skp1-Cullin1-F box protein), also known as CRL1, as its
founding member. CRL consists of four components: an adaptor
protein (e.g. SKP1), one of seven cullin family members (e.g., Cul-1), a
substrate recognizing receptor (e.g., F-box protein Skp2), and one of
two small RING family proteins: RBX1/ROC1 and SAG/RBX2/
ROC2. While the receptor protein determines the substrate
specificity, the cullin-RING components constitute the core
ubiquitin ligase activity. Activity of CRL also requires cullin
neddylation. By promoting the ubiquitylation of various regulatory
proteins for targeted degradation by 26S proteasome, CRL regulates
many biological processes, including apoptosis, cell cycle
progression, signal transduction, DNA replication, embryogenesis,
and tumorigenesis [1,2].SAG (Sensitive to Apoptosis Gene), also known as RBX2 (RING
box protein-2), ROC2 (regulator of cullins-2), or RNF7 (RING
finger protein 7), an evolutionarily conserved small RING-containing
protein with 113 amino acids, is the second member of the ROC/
RBX/RING component of the CRL E3 ubiquitin ligases. In response
to various stimuli (e.g., ROS, mitogen and hypoxia), SAG is induced
at the transcriptional level by transcription factors AP-1 and HIF1α,
respectively. Induced SAG then recruits other components of CRL
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Figure 1. Sag disruption suppresses cell growth: (A and C). MEF cells were generated from E10.5 embryos after intercrossing of Saggt/+
mice (A) or from E13.5 embryos after intercrossing of Sagfl/+ mice, followed by Ad-Cre or Ad-GFP infection (C). MEF cells were then
subjected to western blotting for Sag and actin. (B and D) PrimaryMEFs with indicated genotypes were cultured in a 96-well plate for up to
5 days. The ATP-lite proliferation assay was used to measure cell growth every 24 hours. Shown is mean ± SEM (n = 3). (E) BrdU-based
proliferation assay. Data are shown mean ± SEM from three independent experiments. *P b .05. Scale bar represents 100 μm.
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substrates, including c-Jun [3], HIF-1α [4], IκBα [5,6], Nf-1 [7],
NOXA [8], p27 [9], and pro-caspase-3 [10] in a cell context,
temporal, and spatial dependent manner. In human tissues, SAG
overexpression was detected in carcinomas of lung, colon, stomach
and liver, which is associated with poor prognosis in lung cancer
patients [8,11,12]. In whole animals, SAG over-expression via
injection of SAG expressing recombinant adenovirus or transduction
of a Tat-SAG fusion protein protected mouse brain tissues from
ischemia/hypoxia-induced damage [13,14]. SAG transgenic expres-
sion in mouse skin inhibited tumor formation at the early stage by
targeting c-Jun/AP1, but enhanced tumor growth at the later stage by
targeting IκBα to activate NFκB in a DMBA-TPA carcinogenesis
model [6], and promoted UVB-induced skin hyperplasia by targeting
p27 [9]. Targeted Sag deletion in mouse caused embryonic lethality
at E11.5-12.5, which is associated with overall growth retardation,
induction of apoptosis, and poor vasculogenesis [7]. Conditional Sag
deletion in endothelial cells also caused embryonic lethality around
E15.5 [15]. Finally, we recently showed that Sag is required for lung
tumorigenesis triggered by KrasG12D [16]. However, it is unknown
whether Sag is required for proper cell proliferation, or for
immortalization, induced by a mutant Kras.
In this study, we investigated these roles of Sag E3 ligase and report
here that Sag is required for proliferation and Kras-inducedimmortalization of mouse embryonic fibroblasts (MEFs). We showed
that genetic deletion of Sag remarkably suppresses proliferation and
abrogates immortalization by inducing senescence. Mechanistically,
we found that Jun-B, a transcription factor, that drives p16
expression, is a novel substrate of Sag E3. Targeted Sag deletion
causes accumulation of Jun-B to transactivate p16, which in turn
induces senescence. Significantly, simultaneous deletion of Cdkn2a, a
gene encoding p16, completely rescued senescence phenotype,
regardless of KrasG12D status. We further found that Sag deletion
significantly inactivates Mapk signaling pathway by directly inhibit-
ing constitutively active KrasG12D activity. Taken together, our
results demonstrated that Sag is a growth essential gene required for
cell proliferation as well as for Kras-induced immortalization,
indicating that Sag plays a role at very early stage of neoplastic
transformation. Thus, Sag targeting may have a value for chemopre-
vention, as well as for senescence-based cancer therapy, particularly in
human cancers harboring a mutant Kras.
Results
Sag Disruption Suppresses Growth of MEFs
We recently found that Sag inactivation via the gene trap (gt)
approach induced embryonic lethality at E11.5-12.5 stage, which is
associated with growth retardation, induction of apoptosis, and poor
CA
DB
Figure 2. Sag disruption induces senescence with p16 accumulation: (A-C). MEF cells with indicated genotypes were grown on coverslips
and photographed (top panel) or stained with anti-p16 Ab (bottom panel) (A and B), or SA-β-Gal staining (C). Two independent Sagfl/fl MEFs
were either infected with Ad-Cre or Ad-GFP control for 72 hours, followed by IB analysis with indicated Abs (D). **P b .01. Scale bar
represents 100 μm.
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MAPK signals via Nf1 accumulation.[7] To further define the role of
Sag in cell proliferation, we generated primary MEFs and found that
while early passage MEF cells from Sag+/+ or Saggt/+ (not shown)
mice proliferated well with a doubling time of ~48 hours, Saggt/gt
MEF cells underwent a complete growth arrest (Figure 1, A and B).
To further confirm this finding, we generated MEFs from conditional
Sagfl/fl mice. [15,16] Sagfl/fl MEFs upon infection with Ad-Cre, but
not Ad-GFP control, showed a complete elimination of Sag protein
(Figure 1C) and complete growth arrest, as measured by ATP-lite
proliferation assay (Figure 1D) and BrdU incorporation assay
(Figure 1E). Thus, Sag is required for proper growth of MEFs.
Sag Disruption Induces Premature Senescence
Significantly, both Saggt/gt MEFs and Sagfl/fl MEFs after Ad-Cre
infection to eliminate Sag demonstrated a flattened and enlarged
morphology with a positive p16 staining (Figure 2, A and B),
reminiscent of premature senescence [17,18]. Furthermore, at passage
6, about 55% of Sag-null MEFs was stained positively for senescence-
associated β-Gal (SA-β-Gal), as compared to only 2.4% of wild-type
MEFs (Figure 2C). Finally, we found that Sag deletion caused
accumulation of p16, but not of p15, nor p53/p21 (Figure 2D). Thus,Sag inactivation induces a premature senescence phenotype via the p16
pathway, rather than the p15 pathway, nor the p53/p21 axis.
Sag Disruption Causes Jun-B Accumulation to Transcriptionally
Activate p16
Given the fact that p16 contains no lysine residue, it is unlikely that
p16 is a direct ubiquitylation substrate of Sag E3 ligase. We then
determined if accumulation of p16 protein upon Sag deletion is due
to enhanced transcription of p16 mRNA. Indeed, semi-quantitative
RT-PCR analysis in two lines of primary MEFs isolated from two
independent Sagfl/fl embryos showed that p16 mRNA levels were
much higher in Ad-Cre infected MEFs, as compared to MEFs
infected with Ad-GFP control (Figure 3A). Thus, regulation of p16
occurred at the transcriptional level.
Given that Sag is the RING component of SCF E3 ubiquitin ligase
required for its ligase activity, Sag disruption would be expected to
cause the accumulation of its substrates [19]. We next focused on a
known substrate of SCFFbxw7 E3 ligase, Jun-B, [20] which is also a
transcription factor known to positively regulate p16. [21] Indeed, we
found that Sag deletion in MEFs increased Jun-B protein (Figure 3B),
but not Jun-B mRNA (Figure 3A), indicating that Sag-mediated
regulation occurred likely at the posttranslational level. It has been
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Figure 3. Sag disruption causes Jun-B accumulation to transcriptionally activate p16: Jun-B is a novel substrate of Sag E3. (A-C)
Expression of Sag, p16 and Jun-B, and Sag-JunB binding: Two independent Sagfl/fl MEFs were either infected with Ad-Cre or Ad-GFP as
control for 72 hours. One portion of cells was subjected to RT-PCR analysis for mRNA expression (A), second portion for IB for protein
expression (B). wild-type MEFs were used for immunoprecipitation, followed by IB with indicated Abs (C). (D) SAG overexpression
shortens the protein half-life of Jun-B: Flag-SAG plasmid was transfected in H1299 cells. Cells were treated with cycloheximide (CHX; 100
μg/ml) to block new protein synthesis for the indicated time periods and subjected to IB analysis. (E) SAG silencing extends the protein
half-life of JunB: H1299 cells were infected with Lenti-SAG or Lenti-GFP as a control, and then treated with CHX (100 μg/ml), cells were
harvested at the indicated time points and subjected to IB analysis. (F) MLN4924 extends the Jun-B protein half-life: H1299 cells were
pretreated with MLN4924 (1 μM) for 24 hours, and then treated with CHX (100 μg/ml), cells were harvested at the indicated time points
and subjected to IB analysis. Densitometry quantification was performed using ImageJ software with β-actin as the loading control.
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ubiquitylation and degradation of Jun-B, [20] and that Fbxw7 is
associated with Sag for targeted degradation of NF-1[7]. We,
therefore, determined whether Sag-Jun-B could form a complex in
vivo and found that indeed, endogenous Sag is associated with
endogenous Jun-B (Figure 3C). Furthermore, we found Sag
overexpression shortened the protein half-life of endogenous JUN-B
(Figure 3D), whereas Sag silencing extended it (Figure 3E). Finally, we
found that MLN4924, a small molecule inhibitor of NEDD8
activating enzyme, which indirectly inhibits SCF E3 ubiquitin ligase
by cullin deneddylation [1,22], effectively extended the protein half-life
of JUN-B (Figure 3F). Taken together, our results demonstrated
that Jun-B is a novel substrate of Sag E3 ubiquitin ligase and Jun-B
accumulation, as a result of Sag deletion, transactivates p16 to
induce senescence.
Senescence Induced by SagDeletion can be Rescued by Simultaneous
Jun-B Silencing or Cdkn2a Deletion
We next investigated whether accumulated Jun-B or p16 plays a
causal role in senescence induced by Sag deletion. Indeed, we found
that lentivirus-based Jun-B silencing rescued the effect of Sag
deletion, as evidenced by abrogation of p16 increase and suppression
of senescence (Figure 4, A and B). We further crossed Sagfl/fl micewith Cdkn2a-/- mice and generated Sagfl/fl;Cdkn2a-/- mice. MEFs
were generated from these mice, along with Sagfl/fl;Cdkn2a+/+ control
mice, and infected with Ad-Cre to delete Sag or Ad-GFP as the
control (Figure 4C). Remarkably, simultaneously deletion of Cdkn2a,
a gene encoding p16, completed rescued senescence induced by Sag
deletion, as measured by SA-β-Gal staining (Figure 4D), as well as by
3T9 protocol which measures cumulative population doubling time
by serial passaging [23] (Figure 4E).
Sag Disruption Inhibits KrasG12D-Induced Immortalization
by Inducing Senescence
To determine the effect of Sag inactivation on immortalization,
triggered by mutant KrasG12D [24], we generated MEFs from
compound mice with genotypes of LSL-KrasG12D [25] and Sagfl/+ or
Sagfl/fl, respectively. We first confirmed that a) KrasG12D was
activated in MEFs after infection of Ad-Cre, but not Ad-GFP
control, through the Cre-recombinase mediated removal of Lox-
STOP-Lox (LSL) fragment (Figure 5A), and b) Sag was inactivated in
MEFs with genotype of Sagfl/fl, but not Sagfl/+ after Ad-Cre infection
(Figure 5B). We further observed that upon Ad-Cre infection, MEF
cells with KrasG12D;Sagfl/fl genotype showed a reduced growth rate
(Figure 5C) with a premature senescence phenotype starting at
passage 8, as evidenced by a significant increase of SA-β-Gal positive
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Figure 4. Senescence induced by Sag can be rescued by simultaneous Jun-B silencing or Cdkn2a deletion. MEF cells with indicated
genotypes were infected with Ad-Cre or Ad-GFP, followed by transfection with Lenti-Jun-B or Lenti-Cont (scrambled control) [8]. After 3
days, one portion of cells was subjected to IB to measure the levels of Jun-B, p16 and Sag (A), another portion was for SA-β-Gal staining
(B). MEF cells with indicated genotypes were infected with Ad-Cre or Ad-GFP, followed by IB for Sag, p16 and actin (C). MEF cells grown
on coverslips were photographed after SA-β-Gal staining (D). MEF cells were cultured and passaged according to the 3T9 protocol to
measure cellular immortalization and senescence (E). **P b .01. Scale bar represents 100 μm.
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doubling, measured by 3T9 protocol (Figure 5E). In contrast,
KrasG12D;Sagfl/+ MEF cells proliferated well and showed no sign of
senescence up to passage 18 (Figure 5, C–E), indicating an
immortalized phenotype, consistent with what was reported for
KrasG12D;Sag+/+ MEFs [24]. More specifically, MEFs at passage 8
with Sag inactivation and even in the presence of KrasG12D activation
showed a flattened morphology with positive senescence-associated β-
Gal (SA-β-Gal) staining [26] (Figure 5D). Thus, Sag is required for
KrasG12D-mediated immortalization. Mechanistically, we found that
Sag inactivation again fails to cause accumulation of p15 or p53/p21,
but does trigger accumulation of p16 (Figure 5F), which is likely
contributing to senescence induction [27].
Blockage of Kras-Induced Immortalization by Sag Disruption
can be Rescued by Simultaneous Deletion of Cdkn2a
Given that p16 is accumulated in senescent KrasG12D;Sagfl/fl
MEFs, we next determined whether p16 again plays a causal role. We
generated MEFs with the following 4 genotypes: 1) KrasG12D;Sagfl/+;
Cdkn2a+/+, 2) KrasG12D;Sag fl/+;Cdkn2a-/-, 3) KrasG12D;Sag fl/fl;
Cdkn2a+/+, and 4) KrasG12D;Sagfl/fl;Cdkn2a-/- and found Cdkn2a
deletion, which caused completely depletion of p16 protein
(Figure 6A), rescued decreased growth rate of KrasG12D;Sagfl/fl;Cdkn2a+/+ MEFs (Figure 6B). More importantly, Cdkn2a deletion
rescued senescence phenotype seen in KrasG12D;Sagfl/fl;Cdkn2a+/+
MEFs, completely, as measured by the SA-β-Gal staining
(Figure 6C), and partially, as measured by the 3T9 protocol
(Figure 6D). It is worth noting that the rescue effect appears to be
less effective in the presence of KrasG12D, which extended the
senescence occurring time from passage 6 to 9 in Sag-null MEFs
(compare Figure 4E vs. Figure 6D). Nevertheless, p16 plays a key role in
senescence triggered by Sag deletion, largely independent of KrasG12D,
although the senescence process is being delayed if KrasG12D is present.
Sag is Required for the Maintenance of Active Ras-Raf-Erk
Signaling Pathway
Finally, we investigated the potential mechanism by which Sag
deletion abrogates the ability of active KrasG12D to immortalize
primary MEFs. We focused directly on the Kras activity by a classic
RBD (Ras-binding domain of Raf-1) pull-down assay and found that
Sag deletion significantly reduced Kras activity with no effect on total
Ras levels (Figure 7A). Consistent with inactivation of Kras, Ras-
Mapk signaling pathway was also inactivated, as evidenced by
markedly reduction of Erk phosphorylation (Figure 7A). Few recent
studies have shown that Ras/Erk activation is associated with ROS
(reactive oxygen species) generation, which could triggers senescence
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Figure 5. Sag disruption inhibits KrasG12D-induced immortalization by inducing senescence. (A and B) MEFs with indicated genotypes
were infected with Ad-Cre, or Ad-GFP control, followed by PCR-based genotyping and IB to show activation of KrasG12D (A) and
inactivation of Sag (B). (C-F) MEF cells following Ad-Cre infection were tested for proliferation by ATP-lite assay. Shown is mean ± SEM
(n = 3) (C), senescence by morphological observation and SA-β-Gal staining (D) or by a series dilution using 3T9 protocol (E) and protein
expression by IB with indicated Abs in two independent pairs of MEFs (F). **P b .01. Scale bar represents 100 μm.
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activity [5,31,32]. We, therefore, used DCFHDA staining to measure
ROS levels and found that Sag deletion had no significant effect on
ROS generation (Figure 7B), excluding the involvement of ROS in
the process. Finally, we measured the levels of several natural
occurring inhibitors of Ras signalling pathway, including Erbin [33],
Nf1 [7], Rkip [34], Spred2 [35], and Spry2 [36], and found that Sag
deletion caused a moderate increase of Nf1, Rkip and Spred2, but not
Erbin and Spry2 (Figure 7A), suggesting that Nf1, Rkip and Spred2
may contribute to inactivation of KrasG12D pathway.
Discussion
Sag, a stress inducible protein, has been shown to play a significant
role in a variety of cellular processes, including embryogenesis,
vasculogenesis, and apoptosis (for review see [19]). Our recent study
has shown that Sag is involved in tumor angiogenesis [15] and
required for KrasG12D-induced lung tumorigenesis [16]. Here we
report a novel finding that Sag genetic inactivation in MEFs induces
senescence, as evidenced by flattened cellmorphology, enhanced staining of
SA-β-Gal and p16. Mechanistically, we found that senescence triggered by
Sag deletion is caused by p16, not by the p15 pathway, nor the p53/p21
axis.We further showed that Jun-B is a novel substrate of Sag E3 ubiquitin
ligase, as evidenced by a) the binding between Sag and Jun-B under
physiological conditions, likely through Fbxw7, since Sag directly binds to
Fbxw7 [7], and Fbxw7 binds to Jun-B [20], b) Sag overexpression shortens
protein half-life of Jun-B, whereas Sag silencing extends it; and c)pharmaceutical inactivation of Sag E3 by MLN4924 extends Jun-B half-
life. Jun-B, upon accumulated following Sag deletion, transactivates p16
expression to induced senescence. Finally we showed by a genetic rescuing
experiment that p16 accumulation is the cause, not the consequence, of
premature senescence, triggered by Sag deletion. Thus, we identified that
the Sag-JunB-p16 axis regulates proper proliferation ofMEFs by preventing
senescence.
It is well-known that immortalization of primary fibroblasts can be
induced by a single oncogene, whereas transformation will require
collaboration of two oncogenes or one oncogene in combination with
the loss of a tumor suppressor gene [37,38]. It is also known that
overexpression of an active Ras oncogene (Hras or Kras) in primary
MEFs induces premature senescence [18,24], whereas expression of
KrasG12D at physiological levels immortalizes MEFs and induces
proliferation [24]. In this study, we showed that Sag deletion blocks
KrasG12D-induced immortalization again through inducing senes-
cence, although appearance of senescence induced by Sag deletion
was delayed. Mechanistically, we showed that Sag is required for the
maintenance of KrasG12D activity, since Sag deletion significantly
reduces such an activity, leading to inactivation of Ras-Raf-Mapk
signaling pathway. Among few naturally occurring inhibitors of Ras,
we identified that Sag deletion caused moderate increase of Nf1, Rkip
and Spred2. However, accumulated Nf1 is unlikely to inactivate
KrasG12D, since Nf1 with GAP activity is a naturally occurring
inhibitor of wild-type Ras, but not mutant constitutively active Ras,
which has very low intrinsic GTPase activity and insensitive to
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Figure 6. Cdkn2a deletion rescues the senescence phenotype of KrasG12D;Sag-/- MEFs. MEF cells with indicated genotypes were infected
with Ad-Cre, followed by IB for the levels of indicated proteins (A), by ATP-lite assay for proliferation. Data are shownmean±SEM (n= 3) (B),
by SA-β-Gal staining for senescence (C), or by 3T9 protocol for immortalization and senescence (D). **P b .01. Scale bar represents 100 μm.
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Spred2, are not direct inhibitors of KrasG12D, although they block
Ras mediated signaling pathway and contribute to its inactivation.
Thus, exactly mechanism by which Sag deletion inactivates KrasG12D
activity remains elusive. Finally, we showed that abrogation of Kras-
induced immortalization by inducing senescence as a result of Sag
deletion is causally related to p16, but not to ROS generation, and it
can be largely rescued by simultaneous depletion of p16 encoding
gene Cdkn2a.
In summary, we showed here that on one hand, Sag promotes cell
proliferation by inducing ubiquitylation and degradation of Jun-B
to prevent p16 transactivation. On the other hand, Sag cooperates
with KrasG12D to trigger immortalization by maintaining an active
Ras-Raf-Mapk signaling pathway. Likewise, Sag inactivation by
genetic deletion causes Jun-B accumulation to induce p16 expression
and subsequent premature senescence. Sag inactivation also blocks the
Ras-Raf-Mapk signaling pathway to inhibit proliferation (Figure 8).
Future study is directed to elucidate the mechanism by which Sag
maintains KrasG12D in a constitutively active form.
Materials and Methods
Mouse Studies
The Sagfl/fl conditional KO mouse model was generated with exon
1 flanked with loxP sites [16]. Cdkn2a-/- mice were purchased from
Jackson laboratories. All procedures were approved by the Universityof Michigan Committee on Use and Care of Animals. Animal care
was provided in accordance with the principles and procedures
outlined in the National Research Council Guide for the Care and
Use of Laboratory Animals.
Generation and Maintenance of MEFs
MEFs were isolated from day E10.5 or E13.5 embryos, as
described [16]. Briefly, the embryos were washed with DMEM
supplemented with 25 mMHEPES buffer and PBS. The tissue was
then minced with a scalpel and digested with 0.05% trypsin
solution containing 0.53 mM EDTA (Invitrogen Life Technolo-
gies, Carlsbad, CA) for 20 min at 37°C with vigorous shaking. The
tissue mixture was then passed 3 times through an 18G needle to
further dissociate any remaining clumps. The cells from each
embryo were put into a 100-mm dish and incubated at 37°C in a
5% CO2 humidified incubator. MEF media contained 15% FBS,
2mM L-glutamine, 0.1 mM MEM non-essential amino acids and
10 μg/ml gentamycin.
PCR-Based Genotyping
Genomic DNA was isolated from mouse tail tips and was genotyped
using the primer set of PSag-KO-F: 5′-TTCTGGCCAGGTGTGGT
GATATC-3′, and PSag-KO-G: 5′-CTTAGCCTT GGTTGTGTA
GAC-3′ to detect floxed allele (140 bp) andwild-type allele (105 bp). The
primer set for detecting the removal of the Sag targeting fragment (1.3 kp)
is PSAG-KO-Seq-B: 5′-GTAACTCCAGACAATGCTCGCT′-3 and
AB
Figure 7. Sag is required for the maintenance of active Ras-Raf-Erk signaling pathway. MEF cells with indicated genotypes were infected
with Ad-Cre. One portion of cells was subjected to Ras activity assay and IB analysis (A), another portion of cells for ROS measurement.
Data are shown mean ± SEM (n = 3) (B).
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Sag deletion (275 bp) or without Sag deletion (1.6 kb). The primer set
for KrasG12D activation is Kras-CreF: 5′-TCCGAATTCAGTGACTA
CAGA-3′ and Kras-CreR: 5′-CTAGCC ACCATGGTCTGAGT-3′.
Unrecombined 2 loxP band is approximately 500 bp, whereas wildtype is
620 bp.Upon recombination, the 500 bp is lost and a 650 bp 1 loxP band
is present which represents the recombined Kras mutant allele [16].
ATPlite Based Cell Proliferation Assay
Cells were seeded in 96-well plates in triplicates and cell
proliferation was measured with an ATPlite kit (Perkin Elmer,
Boston, MA) [41].
BrdU Incorporation Assay
MEFs after 48-hours of infection with Ad-GFP or Ad-Cre were
serum starved for 18 hours to allow cells arrested at the G0 phase.
BrdU (100 μg/ml) was then added into the culture medium. BrdU
incorporation assay was performed as described previously [42] with
the following modifications. Cells were fixed in 4% PFA-PBS and
BrdU positive cells detected with a 5-Bromo-2′-deoxy-uridine
labeling and detection Kit II (Roche, Indianapolis, IN) and
counterstained with Eosin-Y.Immunoblotting Analysis
MEFs Cells were harvested, lysed in a Triton X-100 lysis buffer and
subjected to immunoblotting analysis [41]. SAG monoclonal
antibody was raised against the RING domain (AA44-113) [8].Other antibodies were purchased commercially as follows: p21 (BD
Transduction Labs, Gibbstown, NJ), p53, Jun-B, p-Erk, Erk, and
Rkip (Cell Signaling, Danvers, MA), p16, p15, Nf1, and Spry2
(Santa Cruz Biotechnology, Santa Cruz, CA), and Spred2 and β-
Actin (Sigma, St. Louis, MO). Anti-Erbin antibody was a gift from
Dr. Lin Mei [33].
Immunohistochemistry Staining
For p16 staining, MEF cells were seeded on a cover slid and grown
for few days before being subjected to p16 immunostaining using
anti-p16 Ab (Santa Cruz Biotechnology, Santa Cruz, CA) with ABC
kits (Vector Labs, Burlingame, CA). The sections were developed
with DAB and counterstained with haematoxylin. Normal goat
serum was used for negative controls.
SA-β-Galactosidase Staining for Senescence
The MEF cells with various indicated genotypes at passages of 4-7
were seeded in 6-well plate. Cells were grown for 2-days to reach sub-
confluency, then subjected to SA-β-gal staining, as described [43].
RT-PCR Analysis
The total RNA was isolated fromMEFs after infection with Ad-GFP
or Ad-Cre using Trizol (Invitrogen, Carlsbad, CA) and cDNA was
made with random primers and SuperScript III reverse transcriptase
(Invitrogen, Carlsbad, CA). The sequence of primers used is as follows:
Jun-B-F: 5′-GCAGCTACTTTTCGGGTCAG-3′, and Jun-B-R: 5′-
TTCATCTTGTGCAGGT CGTC-3′. P16-F: 5′-GAACTCTTT
Figure 8. Mechanism of Sag action in senescence and immortali-
zation: Sag prevents senescence by promoting Jun-B ubiquitylation
and degradation to block p16 expression, and Sag cooperates with
KrasG12D to induce immortalization bymaintaining activeKras activity
and Mapk signaling pathway. Sag deletion induces senescence by
causing Jun-B accumulation to increase p16 expression, and Sag
deletion abrogates immortalization by inactivating Kras activity and
Mapk signaling pathway (see text for details).
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TTGA-3′. Actin-F: 5′-CACAGCTTCTTTGCAGCTCCTT-3′ and
Actin-R: 5′-CGTCATCC ATGGCGAACTG-3′.
Ras Activity Assay
Ras activity was measured by using Ras binding domain of Raf
(RBD) pull-down assay kit (Millipore, Billerica, MA), following
manufacturer's instruction.
ROS Measurement
The MEF cells with various indicated genotypes at passage 4 to 7
were seeded in 60-mm dish. Cells were grown for 2-days to reach sub-
confluency and stained with 20 μMDCFHDA for 30 min in the dark
and analyzed using the flow cytometer equipped with a 488-nm argon
laser as a light source to determine the DCF fluorescence intensity. The
green fluorescence was measured in the FL1 (FITC) channel. The mean
fluorescence intensity (MFI) of 10,000 cells was analyzed by WinMDI
2.8 software. The MFI data were normalized to control levels and
expressed as relative fluorescence intensity (DCF) [44].
Statistical Analysis
Statistical analysis was performed using two-tailed Student's t-test.
All statistical analyses were carried out using the GraphPad Prism
software version 5.01 (GraphPad, SanDiego, CA). Data were expressed
as mean ± SEM of at least 3 independent experiments. P b .05 was
considered statistically significant.Acknowledgements
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